Scarlet fever has traced a strange arc through human history, cycling from a mild childhood nuisance to a mass killer and back again, then re-emerging in the 21st century in ways that caught public health authorities off guard. Caused by toxin-producing strains of the bacterium Streptococcus pyogenes, the disease was once so feared that entire hospital wards were dedicated to isolating its victims. Its story is not just one of medical progress but of a pathogen that keeps reinventing itself through genetic tricks that science is still working to understand.
From Vague Descriptions to a Distinct Disease
For centuries, scarlet fever was tangled up with other rash-producing illnesses. Physicians in the 1600s and 1700s struggled to separate it from measles, and many early accounts describe a generic “scarlet rash” without enough clinical detail to be sure what disease the writer was actually seeing. The English physician Thomas Sydenham, working in the late 17th century, is widely credited with distinguishing scarlet fever as its own entity, separate from measles. Even so, the disease continued to be confused with other febrile rashes well into the 1800s, partly because its severity varied wildly from one outbreak to the next. Some years it killed thousands; other years it barely registered.
That inconsistency is itself a clue to how the disease works. Unlike many infections where the germ alone determines severity, scarlet fever depends on which toxins a particular strain of streptococcus happens to carry. A strain without the right toxin genes causes strep throat but not scarlet fever. This toxin-dependent nature helps explain why the disease seemed to appear, vanish, and reappear throughout recorded history in ways that baffled earlier generations of doctors.
The Deadly 19th Century
The 1800s turned scarlet fever into one of the most feared childhood diseases in Europe and North America. In England and Wales, mortality rose sharply around the 1840s and stayed high for roughly four decades. Analysis of registration data from that period shows the disease swept through in waves with intervals of about five to six years between major epidemics.1PubMed Central. The dynamics of scarlet fever epidemics in England and Wales in the 19th century Fatality rates in some outbreaks reached staggering levels, with scarlet fever ranking alongside diphtheria as a leading killer of children.
Then, around 1880, something changed. The fatal epidemics faded, and the overall death rate from scarlet fever began a long, steady decline. This happened well before antibiotics and before any vaccine. One compelling explanation ties the decline to improving nutrition: scarlet fever mortality dropped in parallel with falling wheat prices, suggesting that the high-mortality era of 1840 to 1880 was partly sustained by widespread malnutrition that left children more vulnerable to severe outcomes.1PubMed Central. The dynamics of scarlet fever epidemics in England and Wales in the 19th century Other researchers have pointed to shifts in the circulating bacterial strains, or to changes in population immunity. Most likely, several factors converged. But the fact that the disease waned on its own, without medical intervention, is one of the more striking episodes in infectious disease history.
Pinning Down the Cause
By the early 20th century, physicians strongly suspected that bacteria were responsible for scarlet fever, but definitive proof required controlled experiments. In the 1920s, American bacteriologists Gladys and George Dick provided the key evidence. They isolated hemolytic streptococci from a nurse who had developed a finger lesion after caring for a scarlet fever patient, then used those bacteria to experimentally induce scarlet fever in human volunteers. From those experiments, they concluded that Streptococcus pyogenes was the cause.2PLoS Pathogens. Streptococcal superantigens and the return of scarlet fever
The Dicks also developed a skin test to detect susceptibility to the disease: injecting a small amount of streptococcal toxin under the skin produced a red reaction in people who lacked immunity. Those who had previously recovered from scarlet fever typically showed no reaction, confirming that the immune response targeted the toxin rather than the bacterium itself. This insight, that the rash and fever were driven by a secreted toxin rather than by bacterial invasion of the skin, reshaped how scientists thought about the disease.
The Toxin-Carrying Viruses Inside the Bacterium
One of the more remarkable twists in the scarlet fever story is that the bacterium does not produce its signature toxins on its own. The genes encoding the key toxins are carried by bacteriophages, viruses that infect bacteria and insert their own DNA into the bacterial genome. When a phage integrates into a streptococcal cell, it can deliver genes for potent toxins called superantigens, transforming an ordinary strep strain into one capable of causing scarlet fever.
This matters because it means the disease can effectively appear out of nowhere. A streptococcal strain circulating harmlessly in a population can acquire new phage elements and suddenly gain the ability to produce scarlet fever toxins. Research on the North-East Asian serotype M12 strains that drove a massive scarlet fever surge in Hong Kong and mainland China linked the outbreak strains to a novel prophage called ΦHKU.vir, which encoded the superantigens SSA and SpeC along with a DNase enzyme called Spd1.3Nature Communications. Prophage exotoxins enhance colonization fitness in epidemic scarlet fever-causing Streptococcus pyogenes In the United Kingdom, a different lineage known as M1UK has been found to acquire additional prophage elements encoding similar virulence genes, and genome sequencing has shown that these strains continue to pick up new toxin-carrying phages over time.4PubMed Central. Acquisition of toxin-encoding lysogenic bacteriophage elements enhances the virulence of pandemic Streptococcus pyogenes M1(UK) Each new phage acquisition can ratchet up virulence, making the strain more dangerous.
How Superantigens Produce the Rash
The toxins at the center of scarlet fever belong to a class of molecules called superantigens, and the name is apt. Ordinary immune responses activate a small, targeted fraction of the body’s T cells. Superantigens bypass the usual specificity requirements by binding simultaneously to immune-cell receptors and to molecules on antigen-presenting cells, triggering a massive, relatively indiscriminate wave of T-cell activation.5PubMed. Molecular requirements for MHC class II alpha-chain engagement and allelic discrimination by the bacterial superantigen streptococcal pyrogenic exotoxin C The result is a flood of inflammatory signals that produces the hallmark widespread rash, high fever, and in severe cases, toxic shock.
This excessive inflammatory activation is what makes scarlet fever distinct from a simple strep throat infection. Both begin with the same bacterium colonizing the throat, but in scarlet fever, the toxin enters the bloodstream and provokes a systemic immune response.6PubMed Central. Proinflammatory synergy between protease and superantigen streptococcal pyogenic exotoxins The rash itself is an effect of dilated blood vessels and inflammation in the skin, driven by the immune system’s overreaction rather than by bacteria physically invading the skin tissue. Once a person’s immune system develops antibodies against the specific toxin, future encounters with the same toxin-producing strain produce strep throat without the rash, which is why scarlet fever is overwhelmingly a childhood disease.
The Clinical Picture
Scarlet fever is classified as an acute, toxin-mediated illness and has a distinctive clinical presentation that, once seen, is hard to mistake for anything else.7Saudi Journal of Medicine and Public Health. Interdisciplinary Clinical Management and Nursing Care Approaches in Scarlet Fever The illness typically begins with a sore throat, fever, and headache. Within a day or two, a rash emerges, often starting on the trunk and spreading outward. The texture of the rash is sometimes described as feeling like sandpaper. The tongue may develop a distinctive coating that peels to reveal a red, bumpy surface, known as “strawberry tongue.”8PubMed Central. Recrudescence of Scarlet Fever and Its Implications for Dental Professionals School-aged children are the group most commonly affected.
One underappreciated aspect of the clinical picture is how variable it can be. Mild cases may involve little more than a faint rash and a sore throat. Severe cases, particularly during the lethal 19th-century epidemics, could involve intense rashes, high fever, tissue damage in the throat, and life-threatening complications including kidney inflammation and heart disease. The wide spectrum of severity, again, relates to which toxins the infecting strain produces and how robust the patient’s immune response is.
The 21st-Century Comeback
By the late 20th century, scarlet fever had faded from public consciousness in most high-income countries. It was still around but was generally mild and easily treated with antibiotics. Then came a series of unexpected surges. In England, population rates of scarlet fever tripled between 2013 and 2014 and continued climbing, reaching the highest notification rate since 1967 by 2016, with more than 19,000 cases reported that year. Hospital admissions for the disease nearly doubled over the same period.9The Lancet Infectious Diseases. England is experiencing an unprecedented rise in scarlet fever with the highest incidence for nearly 50 years The median age of cases was just four years old, and strain analysis revealed a diverse mix of bacterial types, with emm3 and emm12 strains being the most prevalent.
China experienced a parallel resurgence. Annual incidence more than tripled between 2004 and 2011, and the years after 2011 saw roughly twice the average case rate of the preceding period.10PubMed Central. Resurgence of scarlet fever in China: a 13-year population-based surveillance study Cases concentrated in northern and northeastern regions and showed a seasonal pattern peaking in late spring and again in early winter. The median age of onset was six years, and boys were affected roughly one and a half times as often as girls. Similar upticks appeared in South Korea, Vietnam, and parts of Europe, suggesting something broader than a localized outbreak.
No single explanation accounts for the resurgence. Antibiotic resistance does not appear to be a major driver, since the strains involved remain susceptible to penicillin. Instead, the emergence of new toxin-carrying prophages in circulating strains seems to be a central factor. The acquisition of ΦHKU.vir by emm12 strains in Asia and the continued accumulation of prophage elements by M1UK strains in the U.K. point to a pathogen that is actively evolving new capabilities.4PubMed Central. Acquisition of toxin-encoding lysogenic bacteriophage elements enhances the virulence of pandemic Streptococcus pyogenes M1(UK)
The Autoimmune Aftermath
Scarlet fever’s damage does not always end when the rash fades. Streptococcus pyogenes infections, including scarlet fever, can trigger autoimmune complications weeks after the acute illness has resolved. The best known of these are acute rheumatic fever and a kidney condition called post-streptococcal glomerulonephritis. In rheumatic fever, the immune system attacks the heart valves, joints, and sometimes the brain, producing chronic heart disease that remains one of the leading causes of cardiovascular death in low-income countries.
The underlying mechanism involves molecular mimicry. Certain surface proteins on the streptococcal cell, particularly the M protein, share structural similarities with human tissues including cardiac myosin. The immune system, primed to attack streptococcal M protein, generates antibodies that cross-react with the body’s own heart tissue.11PubMed. Human and murine antibodies cross-reactive with streptococcal M protein and myosin recognize the sequence GLN-LYS-SER-LYS-GLN in M protein This sharing of epitopes between streptococcal and host antigens is what drives the autoimmune damage.12PubMed Central. Molecular Mimicry, Autoimmunity, and Infection: The Cross-Reactive Antigens of Group A Streptococci and their Sequelae Prompt antibiotic treatment of strep throat and scarlet fever reduces the risk of rheumatic fever, which is one of the strongest practical arguments for treating these infections quickly even when symptoms are mild.
Why Building a Vaccine Is So Difficult
Streptococcus pyogenes remains one of the most significant human pathogens without an approved vaccine, and the reasons trace back to several compounding problems. The M protein that sits on the bacterial surface is the most obvious vaccine target, but it exists in well over 200 distinct types (known as emm types), and immunity to one type does not protect against others. A systematic review of global strain diversity found that this high variability is a central obstacle to vaccine design.13PubMed. Global Streptococcus pyogenes strain diversity, disease associations, and implications for vaccine development: a systematic review A vaccine based on a handful of M-protein variants might work well in one region and offer little protection in another where different strains circulate.
The molecular mimicry problem compounds the difficulty. Because M protein shares structural features with human cardiac tissue, early vaccine candidates based on whole M protein raised concerns about triggering the very autoimmune complications the vaccine was meant to prevent. Modern approaches focus on conserved regions of the M protein that are less likely to cross-react with human tissue, or on non-M-protein targets altogether, but none has yet reached late-stage clinical approval. The prophage-driven evolution described earlier adds another layer of unpredictability: even if a vaccine targets the right bacterial antigens, the toxin profile of circulating strains can shift as new phages integrate into the bacterial genome.
Diagnosis Then and Now
For most of its history, scarlet fever was diagnosed purely by clinical observation: the rash, the tongue, the peeling skin. The Dick test introduced in the 1920s offered a way to assess immunity but was not a practical diagnostic tool for active disease. Throat cultures became the standard in the mid-20th century, providing definitive identification of Streptococcus pyogenes but requiring overnight incubation.
The modern shift has been toward rapid antigen detection tests, which can identify group A streptococcus from a throat swab in minutes. These point-of-care tests have become especially valuable in the context of recent case surges, enabling faster treatment decisions in settings where waiting for a culture result could mean a delay in starting antibiotics.14PubMed. Scarlet fever – A retrospective case series in the midst of recent upsurge of cases in India Rapid tests are not perfect; they occasionally miss infections that a culture would catch. But for a disease where early antibiotic treatment prevents both complications and transmission, the speed advantage matters.
Behind the scenes, genomic sequencing has transformed how public health agencies track outbreaks. Whole-genome sequencing of streptococcal isolates can reveal which prophages a strain carries, which toxins it can produce, and how closely related outbreak strains are to one another. This kind of surveillance was what linked the English resurgence to a diversity of emm types and what identified the role of ΦHKU.vir in Asian outbreaks.9The Lancet Infectious Diseases. England is experiencing an unprecedented rise in scarlet fever with the highest incidence for nearly 50 years Genomic tools do not help the individual patient in the doctor’s office, but they are reshaping how scientists understand and anticipate the next wave of an old disease that refuses to stay in the past.